Merit Medical Reports Strong Preliminary Q4 Revenue and Announces Founder's Final Board Departure
summarizeSummary
Merit Medical Systems announced strong preliminary Q4 2025 revenue growth and the final departure of its founder, Fred P. Lampropoulos, from the Board, with a new independent Chair appointed.
check_boxKey Events
-
Strong Preliminary Q4 2025 Revenue
Merit Medical reported preliminary unaudited revenue for the fourth quarter of 2025 in the range of $389 million to $395 million, representing approximately 10% to 11% year-over-year growth. Constant currency revenue increased by 8% to 10% year-over-year.
-
Founder's Final Board Resignation
Fred P. Lampropoulos, the company's founder, resigned as a director and Chair of the Board, effective January 4, 2026. This follows his prior resignations as President, CEO, and Executive Chair, marking the conclusion of his leadership transition.
-
No Dispute in Departure
The company explicitly stated that Mr. Lampropoulos's resignation was for personal reasons and not due to any dispute or disagreement with management, the Board, or any matters related to financial reporting or internal controls.
-
New Independent Board Chair Appointed
F. Ann Millner, Ed.D., formerly Merit's Lead Independent Director, was appointed as the new Chair of the Board, effective January 5, 2026. The Board also reduced its size from eleven to ten members.
auto_awesomeAnalysis
Merit Medical Systems reported robust preliminary unaudited revenue for the fourth quarter of 2025, showing strong year-over-year growth. This indicates healthy operational performance and positive business momentum. Concurrently, the company announced the final step in its leadership transition with founder Fred P. Lampropoulos's resignation from the Board, which was explicitly stated as not being due to any disputes or financial disagreements. The appointment of F. Ann Millner, the former Lead Independent Director, as the new Chair of the Board signals a smooth and well-managed transition, reinforcing governance stability. Investors should view the strong revenue as a positive indicator of the company's financial health, while the leadership change, though significant, appears to be a planned and amicable succession.
At the time of this filing, MMSI was trading at $93.18 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.5B. The 52-week trading range was $78.12 to $111.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.